BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35627168)

  • 1. ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy.
    Liu C; Zhang Y; Jian X; Tan X; Lu M; Ouyang J; Liu Z; Li Y; Xu L; Chen L; Lin Y; Xie L
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
    Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteogenomic approach to target neoantigens in solid tumors.
    Verma A; Halder A; Marathe S; Purwar R; Srivastava S
    Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
    Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.
    Müller M; Huber F; Arnaud M; Kraemer AI; Altimiras ER; Michaux J; Taillandier-Coindard M; Chiffelle J; Murgues B; Gehret T; Auger A; Stevenson BJ; Coukos G; Harari A; Bassani-Sternberg M
    Immunity; 2023 Nov; 56(11):2650-2663.e6. PubMed ID: 37816353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
    Tretter C; de Andrade Krätzig N; Pecoraro M; Lange S; Seifert P; von Frankenberg C; Untch J; Zuleger G; Wilhelm M; Zolg DP; Dreyer FS; Bräunlein E; Engleitner T; Uhrig S; Boxberg M; Steiger K; Slotta-Huspenina J; Ochsenreither S; von Bubnoff N; Bauer S; Boerries M; Jost PJ; Schenck K; Dresing I; Bassermann F; Friess H; Reim D; Grützmann K; Pfütze K; Klink B; Schröck E; Haller B; Kuster B; Mann M; Weichert W; Fröhling S; Rad R; Hiltensperger M; Krackhardt AM
    Nat Commun; 2023 Aug; 14(1):4632. PubMed ID: 37532709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
    Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
    Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
    Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSNAD v2.0: A one-stop software solution for tumor-specific neoantigen detection.
    Zhou Z; Wu J; Ren J; Chen W; Zhao W; Gu X; Chi Y; He Q; Yang B; Wu J; Chen S
    Comput Struct Biotechnol J; 2021; 19():4510-4516. PubMed ID: 34471496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSNAdb v2.0: The Updated Version of Tumor-specific Neoantigen Database.
    Wu J; Chen W; Zhou Y; Chi Y; Hua X; Wu J; Gu X; Chen S; Zhou Z
    Genomics Proteomics Bioinformatics; 2023 Apr; 21(2):259-266. PubMed ID: 36209954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neo-intline: integrated pipeline enables neoantigen design through the in-silico presentation of T-cell epitope.
    Li B; Jing P; Zheng G; Pi C; Zhang L; Yin Z; Xu L; Qiu J; Gu H; Qiu T; Fang J
    Signal Transduct Target Ther; 2023 Oct; 8(1):397. PubMed ID: 37848417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.
    Capietto AH; Hoshyar R; Delamarre L
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery.
    Zhang J; Mardis ER; Maher CA
    Bioinformatics; 2017 Feb; 33(4):555-557. PubMed ID: 27797777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
    Turajlic S; Litchfield K; Xu H; Rosenthal R; McGranahan N; Reading JL; Wong YNS; Rowan A; Kanu N; Al Bakir M; Chambers T; Salgado R; Savas P; Loi S; Birkbak NJ; Sansregret L; Gore M; Larkin J; Quezada SA; Swanton C
    Lancet Oncol; 2017 Aug; 18(8):1009-1021. PubMed ID: 28694034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens.
    Cuevas MVR; Hardy MP; Larouche JD; Apavaloaei A; Kina E; Vincent K; Gendron P; Laverdure JP; Durette C; Thibault P; Lemieux S; Perreault C; Ehx G
    Genome Biol; 2023 Aug; 24(1):188. PubMed ID: 37582761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer.
    Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
    Ren Y; Cherukuri Y; Wickland DP; Sarangi V; Tian S; Carter JM; Mansfield AS; Block MS; Sherman ME; Knutson KL; Lin Y; Asmann YW
    Oncoimmunology; 2020; 9(1):1744947. PubMed ID: 32523802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis.
    Wen B; Li K; Zhang Y; Zhang B
    Nat Commun; 2020 Apr; 11(1):1759. PubMed ID: 32273506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens.
    Xiang R; Ma L; Yang M; Zheng Z; Chen X; Jia F; Xie F; Zhou Y; Li F; Wu K; Zhu Y
    Commun Biol; 2021 Apr; 4(1):496. PubMed ID: 33888849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
    Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
    Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.